Displaying 1 - 50 of 12830
| Request date | Organisation name Sort descending | Country | Search type | Topic | Link | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/09/2019 | "S2E Sprint S.r.l. | Italy | Expertise Request | Next Generation Internet of Things (ICT-56-2020) | F&T portal | ||||||
| S2E is a SME providing IT and Security solutions. S2E lean on its own Research & Development Hub, Software Factory and 4 business Units: Development & Data, Infrastructure Integration, Enterprise Mobility, Information Security. We are interested in the integration of a transparent security layer in IoT systems. Our main targets are eHealth in order to protect high sensitive healthcare information in new pervasive eHealth applications and Critical Infrastructures IoT control systems protection. |
|||||||||||
| 29/06/2019 | "S2E Sprint S.r.l. | Italy | Expertise Request | Enabling next-generation of smart energy services valorising energy efficiency and flexibility at demand-side as energy resource (LC-SC3-EE-13-2018-2019-2020) | F&T portal | ||||||
| S2E offers an enjoyable path into Innovation Business. S2E lean on its own Research & Development Hub, Software Factory and in a complete Service Management branched into 4 business Units: Development & Data, Infrastructure Integration, Enterprise Mobility, Information Security. We can provide cybersecurity solution for research projects, supporting law and regulations requirements, and also providing innovative solution to support security levels required by EU in IA and RIA projects. |
|||||||||||
| 29/06/2019 | "S2E Sprint S.r.l. | Italy | Expertise Request | Upgrading smartness of existing buildings through innovations for legacy equipment (LC-SC3-EE-4-2019-2020) | F&T portal | ||||||
| S2E offers an enjoyable path into Innovation Business. S2E lean on its own Research & Development Hub, Software Factory and in a complete Service Management branched into 4 business Units: Development & Data, Infrastructure Integration, Enterprise Mobility, Information Security. We can provide cybersecurity solution for research projects, supporting law and regulations requirements, and also providing innovative solution to support security levels required by EU in IA and RIA projects. |
|||||||||||
| 04/07/2019 | "S2E Sprint S.r.l. | Italy | Expertise Request | Digital security, privacy, data protection and accountability in critical sectors (SU-DS05-2018-2019) | F&T portal | ||||||
| S2E offers an enjoyable path into Innovation Business. S2E lean on its own Research & Development Hub, Software Factory and in a complete Service Management branched into 4 business Units: Development & Data, Infrastructure Integration, Enterprise Mobility, Information Security. We're cybersecurity solution developers and we are interested in the development of advanced security components for privacy, data and system protection in critical infrastructures. |
|||||||||||
| 30/01/2020 | 2.-O LCA CONSULTANTS APS | Denmark | Expertise Offer | Towards sustainable urban air mobility (MG-3-6-2020) | F&T portal | ||||||
| 2.-0 LCA consultants specialises in life-cycle-based sustainability assessments that consistently integrate environmental, social, and economic impacts with state-of-the-art methods and software. More details @ https://lca-net.com/services-and-solutions/ | |||||||||||
| 30/01/2020 | 2.-O LCA CONSULTANTS APS | Denmark | Expertise Offer | Advanced research methods and tools in support of transport/mobility researchers, planners and policy makers (MG-4-8-2020) | F&T portal | ||||||
| 2.-0 LCA consultants specialises in life-cycle-based sustainability assessments that consistently integrate environmental, social, and economic impacts with state-of-the-art methods and software. More details @ https://lca-net.com/services-and-solutions/ | |||||||||||
| 06/11/2018 | 2021.ai | Denmark | Expertise Offer | Supporting the emergence of data markets and the data economy (ICT-13-2018-2019) | F&T portal | ||||||
| With Grace AI Platform we offer all organizations to implement the same AI technologies as used by the technology unicorns and the most AI ambitious Fortune 500 companies. Grace AI Platform supports the entire data science workflow, adhering to our mission: “To bring Machine Learning to every corner of any organisation across the globe.” | |||||||||||
| 06/11/2018 | 2021.ai | Denmark | Expertise Offer | Interactive Technologies (ICT-25-2018-2020) | F&T portal | ||||||
| What is AI as a Service? Developing, utilizing, and expanding the full potential of AI is complex. We offer your organization smooth, well-defined, and secure implementation and adaptation of AI. AI as a Service from 2021.AI ensures your organization resilience and robustness, while removing single point of failure. We help you on the entire AI journey – from defining the first use cases to developing machine learning models through implementation and support in production. |
|||||||||||
| 04/12/2018 | 21SOLUTIONS SPRL | Belgium | Expertise Offer | Innovative solutions for inclusive and sustainable urban environments (TRANSFORMATIONS-03-2018-2019) | F&T portal | ||||||
| 21 SOLUTIONS is a Brussels-based consultancy, specialist in practical implementation of multi-stakeholder community-scale projects throughout the city-region. We support more than 60 "sustainable neigbourhoods" http://www.quartiersdurables.be that have developed >100 community led projects with a reach out of a few thousand citizens. We are also involved in the www.vilco.brussels research project to improve the relations between community led initiatives and local authorities / municipalities. | |||||||||||
| 20/02/2019 | 2W2E GmbH | Switzerland | Expertise Offer | Mining big data for early detection of infectious disease threats driven by climate change and other factors (SC1-BHC-13-2019) | F&T portal | ||||||
| 2w2e is an independent consulting and software development company in the field of hydrology and climate change. https://www.2w2e.com Our paper from EU project related to water resources of Europe is the most downloaded and most cited paper of all the time in the journal of hydrology! Expertise: 1- Modeling small-large scale watersheds, 2- Software development for hydrology (e.g. SWAT-CUP developed by Abbaspour, and Climate Change Toolkit), We could collaborate with health companies |
|||||||||||
| 22/04/2019 | 2W2E GmbH | Switzerland | Expertise Offer | Security for smart and safe cities, including for public spaces (SU-INFRA02-2019) | F&T portal | ||||||
| 2w2e is an independent Swiss consulting company in the field of energy, climate change and extreme event analysis. https://www.2w2e.com. Our paper from EU project about water resources of Europe is the most downloaded and most cited paper of all the time in the journal of hydrology! Our products: SWAT-CUP (developed by Dr. Abbaspour), Climate Change Toolkit, Flood Forecast. Online monitoring system: http://www.swatch21.com/ | |||||||||||
| 20/12/2019 | 2W2E GmbH | Switzerland | Expertise Offer | Developing long-term monitoring and evaluation frameworks for the Common Agricultural Policy (FNR-02-2020) | F&T portal | ||||||
| 2w2e is an enterprise for applied research in the field of water, weather, climate, energy, and ecosystem. Our focus is on watershed modeling and river basin management and climate change analysis. We have experience in the fields of hydrology, water quantity, and quality in watersheds. We model water resources and crop production. Having extensive experience and real results in this area, we are looking for partners and coordinators to form a consortium or we could join the existing one. | |||||||||||
| 20/12/2019 | 2W2E GmbH | Switzerland | Expertise Offer | Monitoring ecosystems through research, innovation and technology (SC5-33-2020) | F&T portal | ||||||
| 2w2e is an enterprise for applied research in the field of water, weather, climate, energy, and ecosystem. Our focus is on watershed modeling and river basin management and climate change analysis. We have many experiences in the fields of hydrology, water quantity, and quality in small and large watersheds. We model water resources. Having extensive experience and real results in this area, we are looking for partners and coordinators to form a consortium or we could join the existing one. | |||||||||||
| 14/03/2019 | 2W2E GmbH | Switzerland | Expertise Request | Big data solutions for energy (DT-ICT-11-2019) | F&T portal | ||||||
| 2w2e is an independent consulting company in the field of hydrology, climate change and calibration of the watersheds. https://www.2w2e.com Our paper from EU project about water resources of Europe is the most downloaded and most cited paper of all the time in the journal of hydrology! https://www.journals.elsevier.com/jo Areas of expertise: 1- SWAT modeling in small-large scale watersheds, 2- Software development for hydrology (e.g. SWAT-CUP developed by Abbaspour, and Climate change Toolkit). |
|||||||||||
| 19/06/2019 | 3AE HEALTH LTD | Cyprus | Expertise Request | SME instrument (EIC-SMEINST-2018-2020) | F&T portal | ||||||
| 3AeHealth Ltd, hereafter 3AHealth, is a Cyprus-based SME that specializes in the design and development of cutting-edge, reliable, and interoperable solutions in the areas of eHealth, mHealth, and image and video data processing and data analytics. | |||||||||||
| 19/06/2019 | 3AE HEALTH LTD | Cyprus | Expertise Offer | Building blocks for resilience in evolving ICT systems (SU-ICT-02-2020) | F&T portal | ||||||
| 3AeHealth Ltd, hereafter 3AHealth, is a Cyprus-based SME that specializes in the design and development of cutting-edge, reliable, and interoperable solutions in the areas of eHealth, mHealth, and image and video data processing and data analytics. | |||||||||||
| 19/06/2019 | 3AE HEALTH LTD | Cyprus | Expertise Request | Security for smart and safe cities, including for public spaces (SU-INFRA02-2019) | F&T portal | ||||||
| 3AeHealth Ltd, hereafter 3AHealth, is a Cyprus-based SME that specializes in the design and development of cutting-edge, reliable, and interoperable solutions in the areas of eHealth, mHealth, and image and video data processing and data analytics. | |||||||||||
| 14/10/2019 | 3DBear Oy | Finland | Expertise Offer | Interactive Technologies (ICT-55-2020) | F&T portal | ||||||
| Hi, We are a Finnish SME which does augmented reality learning application called 3DBear (www.3dbear.io). We've won lot of awards (like Bill and Melinda Gates Foundation top 8 XR education company in the World) and raised $2.5 million financing so far from mostly private sources (VCs from US). We've reached 100 000 users and thus have significant end user reach. We have implemented multi-user AR in our product. We'd be interested in joining as an end user to a consortium in this call. |
|||||||||||
| 28/01/2020 | 4RealSim Services B.V. | Netherlands | Expertise Offer | Accelerating the uptake of computer simulations for testing medicines and medical devices (SC1-DTH-06-2020) | F&T portal | ||||||
| 4RealSim Services offers advanced Computer Modelling and Simulation services for the Life-Science & Medtec sector. These are typically multi-physics simulations (Finite Element Method / Computational Fluid Dynamics / Optimization / Fatigue) that support the development process of Medical Devices – from concept evaluations to design verification & validation testing. Computer models can be created based on patient specific 3D Medical Imaging Data and tested in a virtual patient environment accoun | |||||||||||
| 23/08/2020 | 4Science Sp. z o.o. | Poland | Expertise Request | The role of consumers in changing the market through informed decision and collective actions (LC-SC3-EC-1-2018-2019-2020) | F&T portal | ||||||
| ‘Regulatory & Legal’, ‘Socio-Economic’, ‘Ethical’ – there are the topics with which we are interested to participate in this call. Contact: dr hab. Robert Zajdler, email: [email protected] or Michal Skwierczynski, email: [email protected]. 4Science is a non-profit organisation combining the experience of the world of science and business. We focus on the following areas: biotechnology, clean energy, chemistry, smart cities, green deal, artificial intelligence. |
|||||||||||
| 23/08/2020 | 4Science Sp. z o.o. | Poland | Expertise Offer | Enabling next-generation of smart energy services valorising energy efficiency and flexibility at demand-side (LC-SC3-B4E-14-2020) | F&T portal | ||||||
| ‘Regulatory & Legal’, ‘Socio-Economic’, ‘Ethical’ – there are the topics with which we are interested to participate in this call. Contact: dr hab. Robert Zajdler, email: [email protected] or Michal Skwierczynski, email: [email protected]. 4Science is a non-profit organisation combining the experience of the world of science and business. We focus on the following areas: biotechnology, clean energy, chemistry, smart cities, green deal, artificial intelligence. |
|||||||||||
| 23/08/2020 | 4Science Sp. z o.o. | Poland | Expertise Offer | Upgrading smartness of existing buildings through innovations for legacy equipment (LC-SC3-B4E-3-2020) | F&T portal | ||||||
| ‘Regulatory & Legal’, ‘Socio-Economic’, ‘Ethical’ – there are the topics with which we are interested to participate in this call. Contact: dr hab. Robert Zajdler, email: [email protected] or Michal Skwierczynski, email: [email protected]. 4Science is a non-profit organisation combining the experience of the world of science and business. We focus on the following areas: biotechnology, clean energy, chemistry, smart cities, green deal, artificial intelligence. |
|||||||||||
| 27/04/2020 | 4WARD ENERGY RESEARCH GMBH | Austria | Expertise Request | The role of consumers in changing the market through informed decision and collective actions (LC-SC3-EC-1-2018-2019-2020) | F&T portal | ||||||
| We are an Austrian research company with 10 years of experience in (inter-)national projects. We have worked on community driven energy projects gaining expertise on national electricity regulation and the development and demonstration of business models. Currently we are providing feedback to the development of the national implementation of Renewable and Citizen Energy Communities in Austria. For more information contact us or visit us under www.4wardenergy.at. |
|||||||||||
| 29/11/2019 | 6DME Limited | UK | Expertise Offer | Novel high performance materials and components (RIA) (LC-SPIRE-08-2020) | F&T portal | ||||||
| 6DME Limited is an additive manufacturing research and development company that specialises in the creation of advanced metallic alloys, metal matrix composites and optimised AM process parameter sets. Our vision is to create sustainable enhanced performance materials and components through the application of advanced simulation, custom materials and additive manufacturing technologies. |
|||||||||||
| 25/03/2019 | A-Team Marketing & Consulting | Serbia | Expertise Offer | Technologies to enhance border and external security (SU-BES02-2018-2019-2020) | F&T portal | ||||||
| We are offering expertise as a project partner under Call: Technologies to enhance border and external security SU-BES02-2018-2019-2020, sub-topic 3: [2019] Security on-board passenger ships. With more that two decades of maritime engagement we have large experiance regarding security on the ships and we believe that our expertise and ideas can significantly improve security on passenger ships according to the growing challenges and specific constraints we are facing on board. | |||||||||||
| 15/02/2018 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Artificial Intelligence (ICT-26-2018-2020) | F&T portal | ||||||
| Biovista is a leader in augmented intelligence & in-silico drug development services focusing on systematic drug repurposing, AE prediction, biomarker discovery & validation for clinical trial optimization. Biovista’s technology uses AI, big data analytics approaches to identify non-obvious mechanism-of-action links between drugs & diseases and assess the B/R profile of repositioned therapies in indications of interest. Collaborators include hospitals, pharma, IT companies and patient groups. | |||||||||||
| 15/02/2018 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment (SC1-DTH-01-2019) | F&T portal | ||||||
| Biovista is a leader in augmented intelligence & in-silico drug development services focusing on systematic drug repurposing, AE prediction, biomarker discovery & validation for clinical trial optimization. Biovista’s technology uses AI, big data analytics approaches to identify non-obvious mechanism-of-action links between drugs & diseases and assess the B/R profile of repositioned therapies in indications of interest. Collaborators include hospitals, pharma, IT companies and patient groups. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Accelerating the uptake of computer simulations for testing medicines and medical devices (SC1-DTH-06-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Use of Real-World Data to advance research on the management of complex chronic conditions (SC1-DTH-12-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care (SC1-DTH-13-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 17/06/2020 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | FET Proactive: emerging paradigms and communities (FETPROACT-EIC-07-2020) | F&T portal | ||||||
| BIOVISTA is a leading supplier of drug repurposing services & related AI tech infrastructure supporting the discovery of non-obvious connections between concepts and the visualization and analysis of such connections. We wish to join a consortium targeting the "digital twin" area of this call. We are offering experience in modelling of biological processes mapping healthy and disease states, with an interest in "fundamental/primordial" processes & properties e.g. redundancy, equilibrium etc. | |||||||||||
| 17/06/2020 | A. PERSIDIS & SIA OE | Greece | Expertise Request | Intelligent security and privacy management (SU-DS02-2020) | F&T portal | ||||||
| BIOVISTA is a leading supplier of drug repurposing services & related AI tech infrastructure supporting the discovery of non-obvious connections between concepts and the visualization and analysis of such connections. We wish to join a consortium targeting areas C and D in a capacity of end user. We wish to for our VIZIT platform to benefit from outcome such that VIZIT end users (biology researchers) are offered a fully secure and privacy protecting research environment. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Scaling up innovation for active and healthy ageing (SC1-HCC-08-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | AI for Genomics and Personalised Medicine (DT-TDS-04-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 28/08/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Software Technologies (ICT-50-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 16/09/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Multi-omics for genotype-phenotype associations (RIA) (BIOTEC-07-2020) | F&T portal | ||||||
| Biovista team integrates and analyzes biomedical -omics data of various types, both from high-throughput experiments and the scientific literature. Our technologies have been used successfully to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & assess adverse event profiles of drugs. Collaborators include hospitals, pharma/IT companies and patient groups. Biovista is the recipient of multiple IT and HEALTH-related EU R&D project awards. | |||||||||||
| 15/02/2018 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | HPC and Big Data enabled Large-scale Test-beds and Applications (ICT-11-2018-2019) | F&T portal | ||||||
| Biovista is a leader in augmented intelligence & in-silico drug development services focusing on systematic drug repurposing, AE prediction, biomarker discovery & validation for clinical trial optimization. Biovista’s technology uses AI, big data analytics approaches to identify non-obvious mechanism-of-action links between drugs & diseases and assess the B/R profile of repositioned therapies in indications of interest. Collaborators include hospitals, pharma, IT companies and patient groups. | |||||||||||
| 28/08/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | AI for Health Imaging (DT-TDS-05-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 28/02/2018 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Big Data technologies and extreme-scale analytics (ICT-12-2018-2020) | F&T portal | ||||||
| Biovista is a leader in augmented intelligence & in-silico drug development services focusing on systematic drug repurposing, AE prediction, biomarker discovery & validation for clinical trial optimization. Biovista’s technology uses AI, big data analytics approaches to identify non-obvious mechanism-of-action links between drugs & diseases and assess the B/R profile of repositioned therapies in indications of interest. Collaborators include hospitals, pharma, IT companies and patient groups. | |||||||||||
| 05/02/2018 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Exploiting the full potential of in-silico medicine research for personalised diagnostics and therapies in cloud-based environments (SC1-DTH-07-2018) | F&T portal | ||||||
| Biovista is a leader in augmented intelligence & in-silico drug development services focusing on systematic drug repurposing, AE prediction, biomarker discovery & validation for clinical trial optimization. Biovista’s technology uses AI, big data analytics approaches to identify non-obvious mechanism-of-action links between drugs & diseases and assess the B/R profile of repositioned therapies in indications of interest. Collaborators include hospitals, pharma, IT companies and patient groups. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data (SC1-BHC-06-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 27/08/2018 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Interactive Technologies (ICT-25-2018-2020) | F&T portal | ||||||
| Biovista is a leader in augmented intelligence, data mining technologies and big data analytics. Biovista’s predictive platform uses these technologies to address drug development questions, such as drug repurposing, AE prediction and biomarker discovery & validation for clinical trial optimization. Collaborators include hospitals, pharma, IT companies and patient groups. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Big Data Innovation Hubs (DT-ICT-05-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | AI for the smart hospital of the future (DT-ICT-12-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Big Data technologies and extreme-scale analytics (ICT-51-2020) | F&T portal | ||||||
| Biovista is an SME that offers augmented intelligence & in-silico drug development services with a focus on drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s technology uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma, IT companies and patient groups. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies (SC1-DTH-02-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 10/07/2019 | A. PERSIDIS & SIA OE | Greece | Expertise Offer | Interactive Technologies (ICT-55-2020) | F&T portal | ||||||
| Biovista is an SME that uses augmented intelligence & in-silico technologies to address drug development problems, such as drug repurposing, adverse event prediction & biomarker discovery for clinical trial optimization. Biovista’s predictive platform uses big data analytics approaches to identify non-obvious mechanism-of-action links between drugs, pathways & diseases & to assess the risk profile of drugs in indications of interest. Collaborators include hospitals, pharma/IT companies and PAGs. | |||||||||||
| 19/03/2018 | A.P.E. RESEARCH SRL | Italy | Expertise Request | Real-time nano-characterisation technologies (RIA) (DT-NMBP-08-2019) | F&T portal | ||||||
| APEResearch is an high-tech company specialised in the production of high-resolution scanning probe microscopes (STMs, AFMs, KPFMs, C-AFMs and SNOMs) and develops new biological analysis methods of investigation based on SPMs. Applications:Material Science, Surface Science, Biology, Chemistry, Medicine. APE will be able to develop new specific tools for R&D projects and also to perform the materials characterization for partner's needs. APE managed several EU R&D projects within FP7 and H2020 | |||||||||||
| 19/03/2018 | A.P.E. RESEARCH SRL | Italy | Expertise Request | Adopting materials modelling to challenges in manufacturing processes (RIA) (DT-NMBP-10-2019) | F&T portal | ||||||
| APEResearch is an high-tech company specialised in the production of high-resolution scanning probe microscopes (STMs, AFMs, KPFMs, C-AFMs and SNOMs) and develops new biological analysis methods of investigation based on SPMs. Applications:Material Science, Surface Science, Biology, Chemistry, Medicine. APE will be able to develop new specific tools for R&D projects and also to perform the materials characterization for partner's needs. APE managed several EU R&D projects within FP7 and H2020. | |||||||||||
| 22/04/2020 | A.P.E. RESEARCH SRL | Italy | Expertise Offer | FET Innovation Launchpad (FETOPEN-03-2018-2019-2020) | F&T portal | ||||||
| APEResearch is nano-tech company specialised in the production of high-resolution scanning probe microscopes (STMs, AFMs, KPFMs, C-AFMs and SNOMs) and develops new biological analysis methods of investigation based on SPMs. APE will be able to develop new specific tools for R&D projects and also to perform the materials characterization for partner's needs. APE managed several EU R&D projects within FP7 and H2020. | |||||||||||